Petfood Industry magazine, in its May 2019 issue, found that Mars Petcare Inc., Nestlé Purina PetCare, Hill’s Pet Nutrition, Diamond Pet Foods and General Mills combined last year to sell $39.3 billion worth of pet food worldwide. Together they took in 43% of the $91.1 billion that the market research firm Euromonitor International believes was spent on pet food globally.
Each of the five companies sells veterinary formulas that make up a minority share of overall revenue. They and the one outlier are:
- Mars Petcare, the owner of Royal Canin therapeutic diets and mass-market brands such as Pedigree and Iams. Petfood Industry estimated total worldwide sales at $18.1 billion in 2018.
- Nestlé Purina, which makes Purina Pro Plan Veterinary Diets as well as more than 20 consumers brands, such as Alpo, Beneful and Castor & Pollux. Total sales reached $13.2 billion.
- J.M. Smucker, which has no veterinary line but sold $2.9 billion in pet food through brands ranging from Meow Mix and Kibbles ’n Bits to Gravy Train and Rachel Ray’s Nutrish.
- Hill’s Pet Nutrition, whose $2.3 billion in 2018 revenue came from veterinary-channel Prescription Diets and mainstream brands Science Diet, Ideal Balance and Healthy Advantage.
- Diamond Pet Foods, which launched the Diamond Care therapeutic line in 2016. The company sold $1.5 billion worth of food in 2018, mostly from Diamond Naturals, Premium Edge and Taste of the Wild.
- General Mills, which paid $8 billion for Blue Buffalo in 2018. Blue makes the Natural Veterinary Diet line as well as Basics, Wilderness, Freedom and Life Protection Formula.
Petfood Industry did not break out sales of therapeutic diets.
The American Pet Products Association estimated that the U.S. pet food market totaled $30.32 billion in 2018. The market research firm Packaged Facts reported that retail sales of dog and cat food reached $27.15 billion.
See also this link
The latest articles
CULT Food starts cultivated pet food regulatory race in the US
A subsidiary of the Canadian cell-based firm is to file a feeding trial to seek approval to sell the product in the country.
Purina witnessing a deceleration, admits Nestlé’s CFO
The multinational’s pet portfolio increased sales in the first half of 2024. GlobalPETS dives into the latest earnings.
American biotech companies receive $36 million in investments
California-based NovoNutrients and Digestiva to scale their footprints in alternative protein.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.